Details on patient characteristics meeting MR spectroscopy quality criteria
| Characteristics | All Patients (n = 30) |
|---|---|
| General | |
| Age (median) (range) (yr) | 41.1 (27.3–78) |
| Female sex (No.) | 63% (19) |
| Histology according to 2016 WHO Classification of Tumors of the Central Nervous System | |
| Glioblastoma, IDH wild-type, WHO IV (No.) | 17% (5) |
| Gliosarcoma, IDH wild-type, WHO IV (No.) | 3% (1) |
| Glioblastoma IDH-mutant, WHO IV (No.) | 3% (1) |
| Anaplastic astrocytoma, IDH wild-type, WHO III (No.) | 3% (1) |
| Anaplastic astrocytoma, IDH-mutant, WHO III (No.) | 33% (10) |
| Diffuse astrocytoma, IDH wild-type, WHO II (No.) | 0% (0) |
| Diffuse astrocytoma, IDH-mutant, WHO II (No.) | 10% (3) |
| Anaplastic oligodendroglioma, IDH-mutant and 1p/19q co-deleted, WHO III (No.) | 17% (5) |
| Oligodendroglioma, IDH-mutant and 1p/19q codeleted, WHO II (No.) | 13% (4) |